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ABSTRACT
Nutritional immunomodulation represents a new frontier area of research for achieving rational goals of 
effi cient and healthy livestock production, as continuous genetic selection and intensive productions systems 
have made the animals highly susceptible to various pathogens. In this study, the amelioration of haematinic 
and immunomodulator on chicken infectious anemia virus (CIAV) induced immmunosupression was studied, 
with regard to haematological and immunological parameters. Vaccines against Newcastle disease (ND) and 
infectious bursal disease (IBD) were used as markers for immunological parameter studies. A total of 80 specifi c 
pathogen free (SPF) broiler chicks, negative for CIAV antibodies, were randomly divided into four groups 
(Group I-IV) and were vaccinated against ND and IBD on days 1 and 12, respectively. All chicks of groups 
II, II and IV were inoculated with CIAV intramuscularly on day 15 of the study, while  group I served as 
control. The chicks of group III and IV were treated with a haematinic (haemocare) and haematinic (haemocare) 
+ immunomodulator (Immuno care), respectively, in drinking water for the entire study period (28 days). 
Live body weights, haematological parameters, along with humoral immune response (HIR) were measured 
at regular intervals. The CIAV infected groups showed a signifi cant decline in cell count of erythrocyte and 
most leukocyte lineages, reduction in live body weights, and antibody titres against ND and IBD viruses. The 
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intensity of body weight loss, anaemia, leukopenia and depressed humoral immune responses were less severe 
in CIAV infected chicks fed with haematenic and immunomodulator supplementation diets. Interestingly, dually 
treated chicks (group IV) had a signifi cantly higher response than the group treated by haematinic alone . In 
conclusion, the use of immunomodulator plus haematinic supplementation is suggested for providing better 
protection compared to haematinic supplementation alone, and the combination can be used for prophylaxis and 
therapeutic purposes against CIA, an economically important and emerging disease of poultry. 
Key words: chicken infectious anaemia, immunotherapeutic, humoral immune response, immuno-
modulators, haematinics________________________________________________________________________________________
Introduction 
Chicken infectious anaemia (CIA) is an emerging disease responsible for considerable 
health problems and economic losses to the poultry industry worldwide (McNULTY, 1991; 
HAGOOD et al., 2000; DHAMA et al., 2008, SCHAT, 2003; SCHAT, 2009; OLUWAYELU, 2010; 
BHATT et al., 2011). The disease is characterized by poor weight gain, severe anemia, 
aplasia of the bone marrow and generalized lymphoid atrophy (McNULTY, 1991; ADAIR, 
2000; SCHAT, 2003; DHAMA et al., 2002; DHAMA et al., 2008). First reported in 1979 in 
Japan, the etiological agent of disease, chicken infectious anaemia virus (CIAV), is the 
smallest DNA virus classifi ed within the genus Gyrovirus of family Circoviridae. The 
virus has gained much importance due to its notable characteristics, such as its hardy 
and highly contagious nature, ubiquitous distribution, vertical transmission, latent 
infections of layer fl ocks and infections of SPF eggs, and the potential for inducing 
marked immunosuppression (McILROY et al., 1992; ROSENBERGER and CLOUD, 1998; 
DE HERDT et al., 2001; SCHAT, 2003; ELTAHIR et al., 2011). In India CIAV has been placed 
on the list of emerging viruses which can cause a severe threat to the poultry industry, 
thereby warranting the need for ascertaining the epidemiological status of the disease in 
the country and to devise effective control measures (NATESAN et al., 2006; BHATT et al., 
2011; DHAMA et al., 2008).
Being a potent immunosuppressive agent, CIAV increases the susceptibility of very 
young unprotected chicks to other secondary infections, viz. viral, bacterial and fungal 
agents, and has also been found to depress vaccinal immune responses and production 
performance in fi eld conditions (ADAIR, 2000; TODD, 2000; DE HERDT et al., 2001; 
SCHAT, 2009; HOERR, 2010). The virus also seems to play a key role in the etiology of 
several other multifactorial diseases, viz. haemorrhagic syndrome, haemorrhagic anaemia 
syndrome, infectious/aplastic anaemia, anaemia-dermatitis syndrome, gangrenous 
dermatitis and blue wing disease (BULOW, 1991; POPE, 1991; TORO et al., 2000; HAGOOD 
et al., 2000; SCHAT, 2003; DHAMA et al., 2008). Reliable diagnostics, viz., enzyme linked 
immunosorbent assay (ELISA), virus neutralization (VN) and immunofl uorescent assay 
(IFA), along with recent DNA detection techniques, such as polymerase chain reaction 
(PCR), restriction enzyme (RE) analysis and sequencing, have emerged as effective 
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diagnostic tools and characterizing the virus at genomic level (McNULTY, 1991; POPE, 
1991; DHAMA et al., 2002; DHAMA et al., 2008; SCHAT, 2009; ANCI et al., 2012). Vaccination 
strategies inclusive of live-attenuated and inactivated vaccines are available, and 
recombinant (r)-DNA vaccine and immune complex vaccine have been recently reported 
to be protective (SCHAT, 2009; DHAMA et al., 2008). 
As with other viral infections, there is no specifi c therapeutic approach for the treatment 
of CIA infected birds; however, broad spectrum antibiotics are generally used to control 
or avoid secondary bacterial infections. Birds in convalescent stages can be provided 
with immunostimulants and hematinics to boost their immune system and the process 
of blood formation, respectively (McNULTY, 1991; DHAMA et al., 2002; SCHAT, 2003). 
Therefore, effective therapeutic regimens need to be evaluated to counter the massive 
immunosuppression produced by the disease and to reduce economic losses. The present 
study was therefore undertaken to assess the ameliorative potential of immunomodulator 
and haematinic supplementation in chicks experimentally infected by the CIA virus, and 
to assess their prophylactic and therapeutic potentials by measuring the haematological 
effects and vaccinal responses as immune parameters. 
Materials and methods
Experimental chicks. Specifi c pathogen free (SPF) chicks (n = 80) were obtained 
from Venkateshwara Hatcheries Private Limited, Pune, and maintained in standard 
management conditions and given normal basal ration and water ad libitum. Chicks were 
also given antibiotics for fi rst six days in prophylactic doses to prevent secondary 
bacterial infections. All the experimental procedures on the chicks were carried 
out according to the recommendations and approval of the Institute Animal Ethics 
Committee (IAEC) under the guidelines set forth by the Committee for the Purpose of 
Control and Supervision of Experiments on Animals (CPCSEA).
Virus. Chicken infectious anaemia virus (Indian isolate, strain A; accession No. 
AY583755), maintained in the Avian Disease Section, Division of Pathology, IVRI, 
Izatnagar, UP (India) was propagated in MDCC-MSB1 cells and was used as the challenge 
virus for inducing infection (NATESAN et al., 2006).
Immunomodulator and hematinic. An immunomodulator (Immuno care), consisting 
of: Vitamin E and C, Amino acids, Omega fats, Sodium chloride, Potassium chloride, 
Selenium, Manganese sulphate and Withania somnifera (Ashvagandha), and a hematinic 
(haemocare) consisting of: elemental iron, Vitamin B12 and B6, Folic acid, Potassium 
chloride, Sodium chloride, Vitamin K3, Copper sulphate and Copper chloride. 
Experimental design. For the experimental study, a total of 80 specifi c pathogen free 
(SPF) broiler chicks were divided randomly into four groups (Group I-IV) with 20 chicks 
each. Chicks of all four groups were vaccinated against Newcastle disease (ND) by live 
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attenuated ‘F’ strain (NDV-F) and Georgia strain of infectious bursal disease (IBD) on 
day 1 and 12, respectively. Screening of SPF chicks for absence of CIAV antibodies 
was performed using a commercially available ELISA kit (IDEXX Laboratories, USA) 
on day 14.
Chicks of groups II, III and IV were inoculated with CIAV intramuscularly, at a 
dose of 0.5 mL (104.5 TCID50/0.1mL), on day 15 of the study. The chicks of groups 
III and IV were treated with a haematinic (haemocare) and haematinic (haemocare) + 
immunomodulator (Immunocare), respectively. The haematinic and immunomodulator 
were given 5 mL and 10 mL each per 100 birds in drinking water, for 0-2 weeks and 2-4 
weeks, respectively, for the entire study period of 28 days. The chicks of groups I and 
II served as the healthy (virus negative) control and infected virus control, respectively. 
Chicks of all the groups were monitored for live body weight, haematological parameters 
and immune responses. About 5 mL of pooled blood samples were collected from 5 chicks 
taken randomly from each group on days 14 (0 day post infection, DPI), 21 (7 DPI) and 
28 (14 DPI). The blood was divided into two parts, one part was taken in heparinised vials 
(10-20 IU/mL) for haematological estimations and the second part was taken in sterilized 
vials for serum collection and immunological assay.
Haematological parameters. Haematological parameters, viz., packed cell volume 
(PCV), haemoglobin (Hb), total erythrocyte count (TEC), total leukocyte count (TLC), 
differential leukocyte count (DLC) - percent lymphocyte count (PLC) and percent 
heterophil count (PHC), were measured in the experimental chicks at regular intervals 
(on the 0th, 7th and 14th DPI) as per the standard protocols (CAMPBELL,1995)
Immunological studies. Serum was harvested from coagulated blood using the 
standard protocol, and stored at -20 ºC unti used for determining the humoral immune 
response. The antibody titer was assessed against NDV and IBD vaccines in CIAV 
inoculated chicks with the help of Haemeagglutination Inhibition (HI) and Enzyme 
linked immunosorbent assay (ELISA), respectively. 
Haemagglutination inhibition assay (HI). The HI test was carried out to determine 
the specifi c humoral antibody response to ND vaccination in the experimental chicks. 
The test was conducted using the -procedure as described by ALLAN and GOUGH 
(1974). Two fold serial dilutions of the test sera were made in normal saline solution 
(NSS), pH 7.2, in round bottomed microtitre plates, in a volume of 50 μL. Four HA 
units of ND virus in equal volume (50 μL) was added to each serum dilution, mixed by 
gentle shaking and the plates were kept at room temperature for 10 minutes. Freshly 
prepared 1% RBC suspension was added to each well in 50 μL volume. The negative 
controls were set up by taking NSS and 1% RBC alone, whereas the virus control was 
set up by making serial two-fold dilution of 4 HA virus and adding 1% chicken RBC. 
The plates were incubated at room temperature for 30 minutes or until the RBCs in 
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the control wells formed a clear button at the bottom. The HI-titre of the serum was 
calculated as the reciprocal of the highest dilution of the test sera, showing complete 
inhibition of haemagglutination of RBCs. The mean HI titre (log 2 ) for different groups 
was calculated for comparison.
Enzyme linked immunosorbent assay (ELISA).  ELISA was carried out to determine 
the specifi c humoral antibody response to IBD vaccination in the experimental 
chicks. ELISA was performed by single dilution method as per the procedure described 
by CHANDRASEKHAR (1994). A local Indian isolate of IBD virus adapted in chicken 
embryo fi broblast culture (CEF) (titer log10 4.3 TCID50/mL) was used as antigen for 
ELISA. The concentration of viral antigen was determined by checker board titration. 
Briefl y, the antigen was diluted at 1: 50 in carbonate-bicarbonate buffer (pH 9.5) and 50 
μL of this diluted virus was added to each well of a 96 well ELISA plate (NUNC). The 
plate was incubated overnight at 4 ºC. The next day, antigen coated plates were washed 
three time with PBS-T (phosphate-buffered saline containing 0.05% Tween-20) for 5 
minutes each and tapped thoroughly. The unreacted sites were blocked by adding 100 
μL of 5 % skimmed milk powder to each well of the plate for 1 hour at 37 ºC. The plates 
were again washed as mentioned above. 1: 100 single dilutions of the test serum samples 
were made in another 96 well microtitre plate, by adding 200 μL of dilution buffer and 
2 μL of test serum. The positive control serum (raised in the chicken against purifi ed 
and confi rmed local Indian isolates of the IBD virus, maintained in the Avian disease 
section, IVRI) and the negative serum were also diluted to 1:100 in PBS-T. The diluted 
negative serum was added in 100 μL to the fi rst three wells of the fi rst row (A1, A2, A3)
and 100 μL of diluted positive serum was added to the fi rst three wells of the last row 
(H1, H2, H3) of the ELISA plate, while the last three wells of the last row (H10, H11, 
H12) were kept blank. In the remaining wells of the antigen-coated plate, 100 μL of test 
serum from the dilution plate was transferred to each of the corresponding three wells. 
The plate was again incubated at 37 ºC for 1 hour and washed three times with PBS-T. 
Then 100 μL of rabbit anti-chicken horse radish peroxidase conjugate (Sigma), diluted 
to 1: 5000 in PBS-T, was added to each well and the plates were incubated at 37 ºC 
for 1 hour. To each well of the plate, 100 μL of freshly prepared substrate solution of 
ortho-diphenylenediamine dihydrochloride (OPD) in citrate buffer was added, followed 
by H2O2 and then incubated at 37 ºC for 30 minutes in the dark. The reaction was stopped 
by adding 100 μL of stop solution (1N H2SO4) to each well of the plate. The plate was 
read at 492 nm in an ELISA reader (ECIL Microscan MS 5605). 
The average absorbance of positive and negative controls was calculated from the 
absorbance value of the ELISA plate and the corrected positive control (CPC) value 
was determined, by subtracting the average negative absorbance from average positive 
absorbance.
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The specifi c value (Sp. Value) was calculated using the following formula:
Sp. Value = Average absorbance of test sample - Average absorbance of negative control
The titre was then calculated by
Log10 titre = [1.464 x log10 Sp.]  + 3.197
Titre  = Antilog of log10 titre.
Statistical analysis. The results were analyzed by the standard method (SNEDECOR 
and COCHRAN, 1994).
Results 
Live body weights. The mean live body weights of different groups on day 14 (0DPI) 
were in the range of 350.5 ± 16.06 and 357 ± 21.24 g. Groups challenged with CIAV 
showed a signifi cant (P<0.05) decline in their mean live body weight as compared to the 
control group (I) both on days 21 (7DPI) and 28 (14DPI) of the study. However group 
IV chicks supplemented with immunomodulator and haematinic had signifi cant (P<0.05) 
mean live body weight gain, as compared to group II and III on day 28 (14DPI) (Table 1).
Table 1. Mean live body weight of different treatment groups challenged with CIAV infection
Groups
Mean live body weight (g)
14th day (0 DPI) 21st day (7 DPI) 28th day (14 DPI)
I 350.5 ± 16.06Aa 599 ± 34.22Cb   803 ± 39.74Cc
II   353 ± 17.51Aa  496 ± 48.06Ab 588.5 ± 54.32Ac
III   353 ± 23.83Aa 503.5 ± 53.23ABb    593 ± 48.77Ac
IV   357 ± 21.24Aa  538 ± 32.08Bb    678 ± 40.84Bc
The values (Mean ± SD) having at least one common superscript (Capital letters in columns and small letters in 
rows) do not differ signifi cantly (P<0.05) for any parameter
Hematological parameters. The hematological parameters studied during the 
present study include PCV, Hb, TEC, TLC, DLC in terms of PHC and PHC. The effect 
of haematinic and haematinic + immunomodulator on these haematological parameters 
in CIAV infected chicks are given in Table 2.
The normal value of PCV was found to be 0.33-0.34 (v/v) in normal chicks. Inoculation 
of CIAV was found to decrease normal PCV values on both days 7 and 14 post inoculation 
in a temporal fashion. Both, haematinic and haematinic + immunomodulator treatments 
were found to signifi cantly reduce the effect of CIAV induced PCV reduction; however, 
amelioration was signifi cantly higher (0.26 v/v) in the haematinic + immunomodulator 
Corrected positive control
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treated group than with haematinic (0.23 v/v) alone on the 14th day PI. Regarding Hb 
concentrations, the groups treated with haematinic and haematinic + immunomodulator 
showed signifi cantly lower reduction compared to the infected control group on both the 
7th and 14th DPI. The normal value of Hb concentration (117-119 g/L) was reduced to 
67.66 g/L in CIAV infected chicks, and the highest improvement in Hb concentration was 
recorded in the haematinic + immunomodulator treated (82.06 ± 2.01 g/L) group on the 
14th day PI. Similar to the values of Hb and PCV, TEC also showed a signifi cant reduction 
in CIAV infected compared to normal healthy control chicks on both the 7th and 14th 
Table 2. Effect of haematinic and haematinic + immunomodulator supplementation on 
hematological profi le in CIAV infected chicks.
Parameters Group  No.
CIAV Post inoculation day
0 7 14
Hemoglobin (g/L)
I 119.24 ± 1.00 121.96 ± 2.20C 123.58 ± 2.01C
II 119.14 ± 1.67 a 101.30 ± 1.10Ab 67.66 ± 1.72Ac
III 117.15 ± 2.55a 107.38 ± 2.67Bb 76.09 ± 1.53Bc
IV 118.90 ± 1.27a 116.24 ± 2.09BCa 82.08 ± 2.01Bb
PCV (L/L)
I 0.33 ± 0.01 0.34 ± 0.01C 0.34 ± 0.00C
II 0.32 ± 0.01a 0.28 ± 0.00Ab 0.20 ± 0.01Ac
III 0.32 ± 0.01a 0.29 ± 0.00Bb 0.23 ± 0.00Bc
IV 0.32 ± 0.01a 0.29 ± 0.00Bb 0.26 ± 0.00Dc
TEC (x1012/L)
I 3.36 ± 0.05 3.43 ± 0.06B 3.43 ± 0.09C
II 3.37 ± 0.06a 2.67 ± 0.05Ab 1.99 ± 0.011Ac
III 3.27 ± 0.16a 2.72 ± 0.02ABb 2.20 ± 0.01Bc
IV 3.20 ± 0.01a 3.27 ± 0.05Ba 2.83 ± 0.01Bb
TLC (x109/L)
I 22.17 ± 0.76 23.16 ± 0.31C 22.68 ± 0.60C
II 22.33 ± 1.04a 18.90 ± 0.28Ab 15.88 ± 0.15Ac
III 22.17 ± 1.04a 19.21 ± 0.50Ab 16.27 ± 0.51Ac
IV 22.17 ± 0.76a 21.17 ± 0.71Ba 17.95 ± 0.14Bb
PLC (%)
I 60.17 ± 0.76 60.76 ± 1.55B 59.71 ± 0.67C
II 60.83 ± 1.61a 52.66 ± 0.69Ab 48.50 ± 1.36Ac
III 59.83 ± 1.89a 52.50 ± 0.59Ab 49.67 ± 1.21ABc
IV 60.50 ± 2.18a 54.05 ± 1.08ABb 51.35 ± 1.51BCb
PHC (%)
I 29.13 ± 1.31 30.08 ± 1.22A 30.83 ± 0.45A
II 29.90 ± 1.15a 39.88 ± 2.26Bb 45.22 ± 1.10Cc
III 29.17 ± 0.76a 39.85 ± 2.82Bb 44.33 ± 0.58Cc
IV 29.17 ± 1.26a 37.98 ± 0.98Bb 40.32 ± 0.59Bc
The values (Mean ± SD) having at least one common superscript (Capital letters in columns and small letters in 
rows) does not differ signifi cantly (P <0.05) for any parameter
PCV - packed cell volume, TEC - total erythrocyte count, TLC - total leukocyte count,  PLC - percent 
lymphocyte count, PHC -  percent heterophil count 
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days PI. The normal TLC value was found to be 22-23×109/L, and CIAV infection was 
found to reduce it  on both days 7 (18.9 ± 0.28) and 14 (15.88 ± 0.15) PI, respectively. 
Treatment with haematinic alone was unable to improve the TLC reduction, but 
the combination of haematinic + immunomodulator signifi cantly improved the TLC 
values on both the 7th (21.17 ± 0.71) and 14th days (17.95 ± 0.14) PI, compared to 
the respective CIAV infected control group. The mean PLC values were signifi cantly 
decreased while the PHC % showed an increasing trend in all the CIAV inoculated 
chicks in a temporal fashion. The group treated with haematinic + immunomodulator 
showed signifi cant improvement in both in PLC (51.35 ± 1.51) and PHC (40.31 ± 
0.59) on the 14th DPI. 
Table 3. Effect of haematinic and haematinic + immunomodulator supplementation on NDV and 
IBV vaccine induced humoral immune response in CIAV infected chicks.
Parameters Group No.
CIAV Post inoculation day
0 7 14
HI titre (log2) 
against NDV
I 10.32 ± 0.00 9.99 ± 0.58C 9.32 ± 1.00C
II 10.65 ± 0.58a 7.65 ± 0.58Ab 4.99 ± 0.58Ac
III 10.32 ± 0.00 a 7.99 ± 0.58Ab 5.32 ± 1.00Ac




I 1.49 ± 0.05a 549.69 ± 24.97Cb 963.28 ± 31.69Cc
II 1.66 ± 0.10a 22.04 ± 1.59Ac 16.72 ± 1.84Ab
III 1.51 ± 0.03a 22.17 ± 1.71Ab 20.71 ± 2.21Ab
IV 1.55 ± 0.05a 57.71 ± 2.61Bb 67.07 ± 4.23Bc
The values (Mean ± SD) having at least one common superscript (Capital letters in columns and small letters in 
rows) does not differ signifi cantly (P<0.05) for any parameter
Immunological studies. The antibody titres were assessed against NDV and 
IBD vaccines as markers to determine the effect of haematinic and haematinic + 
immunomodulator treatment on CIAV inoculated chicks. HI and ELISA tests were 
carried out to determine the specifi c humoral antibody response against the NDV and IBD 
vaccines administered to the experimental chicks, respectively. All the groups inoculated 
with CIAV showed a marked reduction in antibody titres against the respective vaccines; 
however signifi cantly higher antibodies were recorded for both NDV and IBD in the 
group treated with haematinic + immunomodulator combination on both the 7th and 14th 
DPI, as compared to the CIAV infected control group. Haematinic treatment alone was 
not found to improve antibody titres signifi cantly (Table 3). 
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Discussion 
Infection with CIAV is of global level signifi cance as it adversely affects poultry 
health and production systems, especially the broiler industry and the production of SPF 
eggs (McILROY et al., 1992, ADAIR, 2000; TODD, 2000; DHAMA et al., 2002; DHAMA et 
al., 2008; SCHAT, 2009; HOERR, 2010). Specifi c clinical signs of the disease are generally 
observed during the fi rst 3-4 weeks of age, when susceptible chicks (without maternally 
derived antibodies) are infected horizontally (McNULTY, 1991; SMYTH et al., 1993; 
HAGOOD et al., 2000; SCHAT, 2003). Although mortality from the disease is not generally 
beyond 5-10% (within 2-4 wks), the associated secondary infections cause more severe 
clinical complications and higher mortality, which are frequently observed in fi eld 
conditions (HAGOOD et al., 2000; BALAMURUGAN and KATARIA, 2006). Keeping in 
view the high metabolic stress, immature immune status and the crucial stage for most 
vaccination programs, the present study was designed to study the amelioration of CIAV 
induced immunosuppression by nutritional supplementation with an immunomodulator 
and haematinic, by determining their effects on hematological and immunological 
parameters.   
Chicken infectious anemia virus causes suppression in the differentiation and 
proliferation of haematopoietic precursor cells, thereby leading to transient destruction of 
erythroblastoid and granuloblastoid cell lineages in the bone marrow which is characterized 
by a drastic reduction in the production of mature red blood cells (erythropoiesis) and 
myelopoiesis, leading to hypoplasia, anaemia and panleukopenia (McNULTY, 1991; 
DHAMA et al., 2008). In the present study, all such changes were clinically observed in the 
CIAV infected chicks.  A signifi cant (P<0.05) decline in Hb, PCV and TEC was observed 
in all the CIAV infected groups as compared to the healthy control chicks. The  leukocyte 
lineages also showed  a signifi cant (P<0.05) decline in TLC, percent lymphocyte count 
and percent basophil and eosinophil counts in the virus challenged groups, as compared 
to the control group. 
Intensive genetic selection for certain specifi c traits, such as meat and egg production, 
in poultry has altered their immune system, and commercial poultry rearing practices 
have made them at increased risk for exposure to pathogenic organisms (KORVER, 
2012). Also, due to the continuous and indiscriminate use of antibiotics, many pathogens 
have now acquired multiple drug resistance and their presence aggravates the stress 
conditions and mortality patterns in birds, especially where immune functions are already 
affected, such as immuno-suppressive CIAV co-infections. In such situations nutritional 
immunomodulation represents a rational goal to achieve effi cient production of healthy 
birds and their economic benefi ts. In this study, a combination of various vitamins, minerals, 
amino acids, fatty acids and inorganic substances, along with the herb Withania somnifera 
(Ashvagandha) was used as an immunomodulating agent. The role of iron, copper, and 
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manganese has been well established in hematopoiesis.  Omega-3 polyunsaturated fatty 
acids play their role by reducing the growth-suppressive effects of infl ammation in poultry 
(KORVER, 2012). Vitamin E acts as free radical scavenger and prevents highly susceptible 
n-3 PUFA from oxidation, and is also said to enhance macrophages phagocytic activity 
and antibody response (FRIEDMAN et al., 1998; KONJUFCA et al., 2004). In the present 
study it was found that nutritional immunomodulation indeed has positive and benefi cial 
effects on weekly body weight gain and the compromised  haematological parameters 
in the infected chicks, as indicated by the lower severity and  intensity of anaemia and 
leukopenia in CIAV infected groups, which were supplemented with haematinic and 
immunomodualtor. Interestingly, the dually treated (haematinic + immunomodulator) 
group IV chicks showed signifi cantly greater improvements, in both body weight gain 
and haematological parameters, as compared to all other infected groups. 
CIAV is believed to be a potent immunosuppressive agent, as it causes marked 
damage of haematopoietic and lymphopoietic tissue, viz. stem cells in bone marrow and 
precursor T-lymphocytes in thymus (GORYO et al., 1989a,b; SMYTH et al., 1993; TODD, 
2000; DHAMA et al., 2008). Immunosuppression so induced is caused at least in part by 
apoptosis induced by VP3 protein (apoptin), not only on the primary lymphoid organs, but 
also on secondary lymphoid tissues, thereby suppressing the helper (CD4+) and cytotoxic 
(CD8+) T-lymphocytes populations (HU et al., 1993; POPE, 1991; PASCUCCI 1997; ADAIR, 
2000; SCHAT, 2003). Poor antibody responses are thus generally observed after CIAV 
infection as a consequence of depressed Th responses (OTAKI et al., 1988a and b).  This 
immunodepression dramatically leads to susceptibility of birds to secondary infections 
(viral, bacterial or fungal origin); depressed vaccinal immunity against other poultry 
pathogens; enhanced vaccination reactions; aggravation of the residual pathogenicity of 
attenuated vaccine viruses and the emergence of a variant virus; and vaccine failure / 
outbreaks (ADAIR et al., 1993; DHAMA et al., 2002; PASCUCCI, 1997; TODD, 2000; DHAMA 
et al., 2008). In the fi eld, CIAV infection seems to cause few signs of disease, however, 
dual infections are more serious. Sub-clinical CIAV infections in older chickens have also 
been reported to cause substantial economic losses, by affecting the growth and health 
of birds. 
In the present study, humoral immune responses (HIR) against NDV and IBD 
vaccines were assayed as indicators to determine the effects of CIAV induced immune 
dysfunctions at an early age. HIR against NDV and IBD were assessed by determining 
the specifi c antibody vaccine titres by employing HI and ELISA, respectively. Previous 
studies by ZHENG and LIU (1996 a,b) indicated  that ND-HI vaccine titres were low in 
CIAV infected birds vaccinated at one day old. While studying the immune response to 
the ND vaccine, RAGLAND et al. (1998) also reported that an increase in CIAV detection 
correlated inversely with ND-HI titres. To overcome this immunosuppressive condition 
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induced by CIAV, an immunomodulator containing Ashwagandha was selected for the 
present study. Several studies have indicated various roles played by Ashwagandha, 
such as: immunoprotective, myeloprotective and  anti-infl ammatory effects, along with 
potentiation of NK cells, T cell proliferation, and humoral and cellular immune response 
(DAVIS and KUTTAN, 2000 and 2002; PADMAVATHI et al., 2005). In the present study, a 
signifi cant decline in the antibody HI titre against NDV and ELISA titres against IBD 
was observed in all the CIAV infected chicks compared to the healthy control group. 
Nutritional supplementation with haematinic plus immunomodulator was found to 
ameliorate the CIAV induced immune suppression, as indicated by the induction of 
higher antibody titres for NDV and IBD vaccines. Similar studies using dietary ascorbic 
acid supplementation found reduced IBDV induced  immunosuppression and improved 
both humoral and cellular immune responses (WU et al., 2000). 
On the basis of the above fi ndings, it may be concluded that nutritional 
immunomodulation may act as a supplementary prophylactic approach for ameliorating 
CIAV induced immune suppression in poultry birds, as indicated by improvements in 
erythrocyte and leukocyte cell lineages. Also the present data highlighted the benefi cial 
effects of dietary supplementation on the humoral branch of the immune system, which 
is necessary for prevention of many important viral pathogens and thus for vaccination 
programs. It is therefore suggested that immunomodulators along with haematinics should 
be supplemented to chicks during their early susceptible age (3-4 weeks) to minimize the 
immunosuppression caused by ubiquitous CIAV. Such types of prophylactic regimes will 
thus not only help alleviate the huge economic losses caused by this important virus, but 
will also improve the general immune status of birds against various other pathogens and 
thereby help to reduce antibiotic usage and the development of drug resistance. 
_______
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SAŽETAK
Imunomodulacija putem hrane predstavlja novo područje istraživanja s ciljem da se postigne učinkovita 
proizvodnja zdrave stoke, jer su trajni genetski odabir i zahtjevni  proizvodni sustavi učinili životinje visoko 
prijemljivima na različite patogene. U ovom je radu, na osnovi hematoloških i imunoloških pokazatelja, istražen 
učinak hematika i imunomodulatora na imunosupresiju izazvanu virusom  zarazne anemije pilića. Cjepiva 
protiv  newcastleske bolesti i zaraznog burzitisa kokoši rabljena su kao osnova za istraživanje imunoloških 
pokazatelja. Ukupno je 80 tovnih pilića, slobodnih od specifi čnih patogenih uzročnika, negativnih na protutijela 
za virus zarazne anemije pilića, bilo nasumce podijeljeno u četiri skupine (I-IV) te prvog dana cijepljeno 
protiv newcastleske bolesti, a 12. dana protiv zaraznog burzitisa kokoši. Svi pilići skupine II, III i IV bili su 
intramuskularno zaraženi virusom zarazne anemije pilića  15. dana pokusa, dok je skupina I bila kontrolna. 
Pilići skupine III dobivali su hematik, a skupine IV hematik i imunomodulator u pitkoj vodi tijekom čitavog 
razdoblja istraživanja (28 dana). Tjelesna masa, hematološki pokazatelji i humoralni imunosni odgovor bili su 
mjereni u pravilnim razmacima. Skupina zaražena virusom zarazne anemije pokazivala je značajni pad broja 
eritrocita i leukocita te smanjenje tjelesne mase i titra protutijela za virus newcastleske bolesti i virus zaraznog 
burzitisa. Gubitak tjelesne mase, anemija, leukopenija i humoralni imunosni odgovor bili su slabiji  u pilića 
zaraženih virusom zarazne anemije koji su dobivali hematik i imunomodulator u hrani. Zanimljivo je da je u 
pilića koji su dobivali dvostruki dodatak (skupina IV) zabilježen značajno bolji odgovor  nego u pilića koji su 
dobivali samo hematik. Može se zaključiti da je upotreba imunomodulatora i hematika pružila bolju zaštitu u 
odnosu na upotrebu samog hematika. Kombinacija se može upotrijebiti za profi laksu i terapiju  protiv zarazne 
anemije pilića, gospodarski važne i emergentne zarazne bolesti. 
Ključne riječi:  zarazna anemija pilića, imunoterapeutik, humoralni imunosni odgovor, imunomodulatori, 
hematici ________________________________________________________________________________________
